Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 52Insulin Resistance 12Metabolic Syndrome 4Hyperandrogenism 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Obesity 3Breast Neoplasms 3Weight Loss 2Rare Diseases 2Infertility, Female 2Hyperinsulinism 2Endocrine System Diseases 2Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostatic Neoplasms 1Premature Birth 1Obesity, Morbid 1Metformin 1Menstruation Disturbances 1Inflammation 1Infertility 1Hyperglycemia 1Head and Neck Neoplasms 1Glucose Intolerance 1Endometrial Neoplasms 1Diabetes Mellitus 1Depression 1

Interventions

Sugars 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Colorectum × Metformin × Clear all
NCT01550900 2013-04-05

Prospective Trial of Metformin - Chemoprevention Role

M.D. Anderson Cancer Center

Phase NA Withdrawn

Colorectum

Data powered by HemOnc (CC BY 4.0) Colophon âš¡